Theratechnologies Inc.
THTXHealthcare · Pharmaceutical Preparations · A8 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
FDA-approved drugs
openFDA · most recent- TROGARZOMar 6, 2018
- EGRIFTANov 10, 2010
Clinical trials
ClinicalTrials.gov · ongoing · next readout firstInterventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Nantahala Capital Management, LlcPassive (13G)Nov 14, 2025
- Summer Road LlcPassive (13G)Sep 29, 2025
- Morgan StanleyPassive (13G)Aug 5, 2025
- Hirschman OrinPassive (13G)Jul 29, 2025
- Soleus Capital Master Fund, L.P.Activist (13D)Apr 11, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Sep 15, 2025 | 186,684 | 1.0 | -10.8% |
| Aug 29, 2025 | 209,355 | 1.0 | -30.3% |
| Aug 15, 2025 | 300,172 | 1.0 | +31.4% |
| Jul 31, 2025 | 228,413 | 1.0 | -26.4% |
| Jul 15, 2025 | 310,492 | 1.0 | +42.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- EFFECTNov 28, 2025
- 15-12GNov 26, 2025
- POS AMNov 26, 2025
- SCHEDULE 13G/ANov 14, 2025
- SCHEDULE 13GSep 29, 2025
- 25-NSESep 25, 2025
- 6-KSep 25, 2025
- 6-KSep 17, 2025
- 6-KSep 12, 2025
- 6-KSep 12, 2025
- 6-KSep 5, 2025
- 6-KSep 2, 2025
- 6-KAug 18, 2025
- 6-KAug 18, 2025
- SCHEDULE 13G/AAug 5, 2025